Literature DB >> 20379173

Empirical analysis of major stem cell patent cases: the role of universities.

Ann E Mills1, Patti M Tereskerz.   

Abstract

Mesh:

Year:  2010        PMID: 20379173     DOI: 10.1038/nbt0410-325

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Health care law--Medicaid--Third Circuit finds providers lack standing to enforce the Medicaid Act.--Pennsylvania Pharmacists Ass'n v. Houstoun, 283 F.3d 531 (3d Cir. 2002), cert. denied, 123 S.Ct. 100 (2002).

Authors: 
Journal:  Harv Law Rev       Date:  2003-01

2.  The global stem cell patent landscape: implications for efficient technology transfer and commercial development.

Authors:  Karl Bergman; Gregory D Graff
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

Review 3.  Can patents deter innovation? The anticommons in biomedical research.

Authors:  M A Heller; R S Eisenberg
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

  3 in total
  2 in total

1.  Theory of knowledge and biotech patents: worlds apart?

Authors:  Myriam M Altamirano-Bustamante; Adalberto de Hoyos; León Olivé
Journal:  Nat Biotechnol       Date:  2011-11-08       Impact factor: 54.908

Review 2.  LULL(ed) into complacency: a perspective on licenses and stem cell translational science.

Authors:  Mahendra S Rao
Journal:  Stem Cell Res Ther       Date:  2013-08-14       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.